BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Iovance Biotherapeutics Announces Approval Of First Clinical Trial Application By Competent Authority In Netherlands For A Phase II Trial Of LN-145 For The Treatment Of Patients With Cervical Cancer

  September 13, 2017

   · 

  4 min read
• Drug Development

  PharmaMar Release: New Positive Data On PM1183 Sees A Response Rate Of 36% As Single Agent In Patients With Advanced And Relapsed Small-Cell Lung Cancer

  September 13, 2017

   · 

  2 min read
• Business

  PLx Pharma Inc. Retains Dr. Efthymios N. Deliargyris As Chief Medical Advisor

  September 13, 2017

   · 

  6 min read
• Business

  ImmuCell Announces Expansion Of Sales And Marketing Team

  September 13, 2017

   · 

  5 min read
• Pharm Country

  Delcath Systems Announces Relisting On OTCQB

  September 13, 2017

   · 

  4 min read
• Business

  Affimed Appoints Dr. Wolfgang Fischer As Chief Operating Officer

  September 13, 2017

   · 

  3 min read
• Policy

  Caprion Biosciences Receives College Of American Pathologists (CAP) Accreditation & Clinical Laboratory Improvement Amendments (CLIA) Certification

  September 13, 2017

   · 

  2 min read
• Pluristem Therapeutics Strengthens Its Position In Asia, Awarded Two New Patents In Hong Kong For Critical Limb Ischemia And Muscle Regeneration

  September 13, 2017

   · 

  4 min read
• Business

  Celldex Announces Departure Of Chief Medical Officer

  September 13, 2017

   · 

  4 min read
• Drug Development

  Zafgen Initiates Phase II Clinical Trial For ZGN-1061 In Patients With Type 2 Diabetes

  September 13, 2017

   · 

  7 min read